Technology Commercialization Office

Showing 2 result(s) for "Drug Screening & Discovery"



A combination-therapy that has the potential to overcome and/or prevent the commonly observed acquisition of sorafenib resistance, which is associated with treatment failure in patients with hepatocellular carcinoma.

Design for a three-dimensional microfluidic bioreactor array; device allows for culturing of a variety of cell types without contamination.